252004-30-1 Usage
Uses
Used in Pharmaceutical Research:
(4-carbaMoyl-3-hydroxy-isothiazol-5-yl)-carbaMic acid phenyl ester is used as a research compound for its potential in the development of new drugs and bioactive compounds. Its unique chemical structure and properties make it a valuable candidate for further investigation and application in the pharmaceutical industry.
Used in Antimicrobial Agents:
In the field of antimicrobials, (4-carbaMoyl-3-hydroxy-isothiazol-5-yl)-carbaMic acid phenyl ester is used as a potential candidate for the development of new agents. Its demonstrated antibacterial and antifungal properties contribute to its significance in this application, offering a promising avenue for combating resistant infections.
Used in Antitumor and Anticancer Activities:
(4-carbaMoyl-3-hydroxy-isothiazol-5-yl)-carbaMic acid phenyl ester is also used as a compound with potential antitumor and anticancer activities. Its study in this area highlights its potential to contribute to the development of novel therapeutic strategies against cancer.
Used in Chemical Synthesis:
The phenyl ester group present in (4-carbaMoyl-3-hydroxy-isothiazol-5-yl)-carbaMic acid phenyl ester provides unique chemical reactivity, making (4-carbaMoyl-3-hydroxy-isothiazol-5-yl)-carbaMic acid phenyl ester valuable for the synthesis of novel organic compounds. Its application in chemical synthesis contributes to the advancement of organic chemistry and the creation of new molecules with potential applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 252004-30-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,2,0,0 and 4 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 252004-30:
(8*2)+(7*5)+(6*2)+(5*0)+(4*0)+(3*4)+(2*3)+(1*0)=81
81 % 10 = 1
So 252004-30-1 is a valid CAS Registry Number.
252004-30-1Relevant academic research and scientific papers
Isothiazole derivatives useful as anticancer agents
-
, (2008/06/13)
The present invention relates to compounds of the formula 1 and to pharmaceutically acceptable salts, prodrugs and solvates thereof, wherein X1, R1, R2and R3are as defined herein. The invention also relates to pharmaceutical compositions containing the above compounds and to methods treating hyperproliferative disorders in mammals by administering the above compounds.
